EFFICACY AND COST OF DIRECT ACTING ANTIVIRALS FOR THE TREATMENT OF HCV INFECTION AMONG HCV MONOINFECTED AND HIV/HCV COINFECTED PATIENTS IN REAL LIFE SETTING